Page 128 - 中国全科医学2022-14

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·1789·

·新进展·

作用于垂体治疗库欣病的药物研究进展

李玲，张会娟 * 扫描二维码
查看原文

【摘要】 由垂体促肾上腺皮质激素腺瘤分泌过多的促肾上腺皮质激素（ACTH）所致的库欣综合征又称为库欣病，
其首选治疗方式为手术切除垂体腺瘤，但部分患者术后治疗效果欠佳或无法进行手术，药物治疗作为二线治疗，也是
必不可少的治疗手段。近年来对库欣病发病机制的研究得到了很大进展，作用于垂体促肾上腺皮质激素腺瘤的药物既
能控制肿瘤增殖也能抑制 ACTH 分泌，为库欣病的药物治疗奠定了理论和临床实践基础。本文致力于论述垂体促肾上
腺皮质激素腺瘤导向药物及其相应作用机制，以期进一步加深对库欣病治疗的了解，为制订更有效的治疗策略提供理
论参考。
【关键词】 库欣综合征；促肾上腺皮质激素；药物疗法；综述

【中图分类号】 R 586.2 【文献标识码】 A DOI：10.12114/j.issn.1007-9572.2021.01.039
李玲，张会娟 . 作用于垂体治疗库欣病的药物研究进展［J］. 中国全科医学，2022，25（14）：1789-1794. ［www.
chinagp.net］
LI L，ZHANG H J. Recent developments in pituitary-directed medical treatment for Cushing's disease［J］. Chinese
General Practice，2022，25（14）：1789-1794.

Recent Developments in Pituitary-directed Medical Treatment for Cushing's Disease LI Ling，ZHANG Huijuan *
Department of Endocrinology and Metabolism，the First Affiliated Hospital of Zhengzhou University，Zhengzhou 450000，China
*
Corresponding author：ZHANG Huijuan，Chief physician，Professor；E-mail：fcczhanghj@zzu.edu.cn
【Abstract】 Cushing's disease is caused by excessive secretion of adrenocorticotropic hormone （ACTH） by hormone-
secreting pituitary adenomas，the first-choice treatment for which is surgical resection of the pituitary adenoma. Medication
therapy is the second-line treatment，and a necessary treatment for some patients with unsatisfactory surgical results or failing
to use the surgery. With recent developments in pathogenesis studies of Cushing's disease，medications specifically targeting
hormone-secreting pituitary adenomas have proven to be effective in controlling the tumor growth，and suppressing the tumor's
secretion of ACTH，which may be a theoretical and practical basis for medical treatment of Cushing's disease. In this review，we
discussed pituitary-directed medical therapies for Cushing's disease and their mechanisms of actions，aiming to increase medical
workers' understanding of this disease，and to offer theoretical evidence for the development of appropriate treatment strategies.
【Key words】 Cushing syndrome；Adrenocorticotropic hormone；Drug therapy；Review

450000 河南省郑州市，郑州大学第一附属医院内分泌与代谢科
* 通信作者：张会娟，主任医师，教授；E-mail：fcczhanghj@zzu.edu.cn
本文数字出版日期：2022-03-31

verproline-homologous protein 2 in adenocarcinoma of the ［90］JIN F J，ZHANG J Y，KUHLMAN T K，et al. A critical role
lung［J］. Clin Cancer Res，2006，12（8）：2449-2454. DOI： for N-WASp in cell migration during central nervous system
10.1158/1078-0432.CCR-05-2566. development［J］. Int J Dev Neurosci，2008，26（8）：855.
［88］TSENG R C，CHANG J W，MAO J S，et al. Growth-arrest- DOI：10.1016/j.ijdevneu.2008.09.091.
specific 7C protein inhibits tumor metastasis via the N-WASP/ ［91］MIYATA S. Cytoskeletal signal-regulated oligodendrocyte
FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung myelination and remyelination［J］. Adv Exp Med Biol，2019，
cancer［J］. Oncotarget，2015，6（42）：44207-44221. DOI： 1190：33-42. DOI：10.1007/978-981-32-9636-7_3.
10.18632/oncotarget.6229 ［92］ZIV-AV A，GILADI N D，LEE H K，et al. RTVP-1 regulates
［89］MENG D F，XIE P，PENG L X，et al. Erratum to：CDC42- glioma cell migration and invasion via interaction with N-WASP
interacting protein 4 promotes metastasis of nasopharyngeal and hnRNPK［J］. Oncotarget，2015，6（23）：19826-19840.
carcinoma by mediating invadopodia formation and activating EGFR DOI：10.18632/oncotarget.4471.
signaling［J］. J Exp Clin Cancer Res，2017，36（1）：33. （收稿日期：2021-06-26；修回日期：2021-09-19）
DOI：10.1186/s13046-017-0503-7. （本文编辑：崔莎）